Healthcare AI spending jumps to $3.7B

Advertisement

Healthcare AI spending reached $3.7 billion in 2026, a 2.5-times increase from the previous year, as investments expand beyond administrative tasks into clinical decision-making and patient engagement, according to a Nov. 16 report from venture capital firm Menlo Ventures.

Healthcare remains the largest industry-specific AI market, accounting for 37% of spending on vertical AI applications, according to the firm’s broader 2026 enterprise AI report.

Healthcare providers accounted for approximately $2.9 billion, or 77%, of healthcare AI spending, up from $1.5 billion in 2025.

Here are five findings from the report:

  1. Epic and Microsoft are gaining ground in ambient AI. Established vendors captured 68% of new spending on AI medical documentation tools in 2026, led by Microsoft Dragon Copilot and Epic’s Art. The ambient scribing market reached $950 million, with established vendors increasing their market share from 33% to 46%.

  2. Clinical AI tools are seeing rapid growth. Spending on clinical AI copilots increased 5.5 times to $550 million, while patient engagement and front-office AI spending grew 4.5 times to $450 million. By comparison, spending on ambient scribes increased 1.6 times, and AI coding and billing grew 1.3 times.

  3. Health systems are taking longer to purchase AI. The average procurement cycle for health systems increased from seven months in 2025 to 10 months in 2026. For outpatient providers, the average rose from five to 11 months. Menlo Ventures attributed the longer timelines to more extensive vendor evaluations, pilots and scrutiny of potential technology partners.

  4. More healthcare organizations are implementing AI. Forty-two percent of healthcare organizations reported implementing industry-specific AI tools, up from 22% in 2025. Health systems led adoption at 52%, followed by outpatient providers at 34%, life sciences organizations at 31% and payers at 23%.

  5. Healthcare organizations are favoring specialized AI tools. Half of healthcare AI spending went toward industry-specific applications, compared with 24% across enterprises overall. The report also found that providers increasingly prefer third-party solutions for certain patient-facing applications, including prior authorization and patient navigation.

The report also found that life sciences AI spending increased from $30 million to $700 million, driven largely by investments in drug discovery and development.

Menlo Ventures’ findings are based on surveys of healthcare decision-makers and market estimates. The firm is an investor in several healthcare AI companies included in its analysis, including OpenEvidence and Assort Health.

Advertisement

Next Up in Artificial Intelligence

Advertisement